Hemostasis reagents portfolio Trusted hemostasis testing solutions that help you deliver consistent results and enhance patient outcomes. siemens-healthineers.com/hemostasis

Siemens Healthineers hemostasis reagents portfolio Siemens Healthineers history of innovation in hemostasis testing spans more than 40 years. Our assays comprise a broad selection of testing solutions to support physicians in making sound diagnostic and therapeutic decisions. The hemostasis assay portfolio ranges from standard PT and APTT testing to the breakthrough von Willebrand factor activity-testing technology in our INNOVANCE® VWF Ac Assay. While innovative testing solutions with LOCI technology enable labs to stay at the cutting-edge of clinical advancements in hemostasis testing, the...

State-of-the art INNOVANCE reagents help expand precision medicine through improved diagnostic accuracy. Instrument availability Systems and analyzers Sysmex® systems Dade Innovin Reagent name Dade Actin Activated Cephaloplastin Dade Actin FSL Activated PTT Dade Actin

Reagent name Reagent description and ready-to-use assay features Multifibren U reagent is a bovine thrombin reagent used in the modified Clauss determination of fibrinogen for the detection of hereditary or acquired hypo- and hyperfibrinogenemia and dysfibrinogenemia. The reagent is insensitive to heparin up to 2.0 U/mL and has a wide measuring range of 0.80–12.00 g/L. Dade Thrombin Dade Fibrinogen Determination Dade Thrombin reagent is an effective reagent for use in the determination (Clauss method) of fibrinogen in the detection of hereditary or acquired hypoand hyperfibrinogenemia, dysfibrinogenemia,...

Instrument availability Systems and analyzers Sysmex® systems Dade Thrombin Reagent name Dade Fibrinogen Determination N Antiserum to Human Fibrinogen Thrombin Time/Batroxobin Time Test Thrombin

Reagent description and ready-to-use assay features Coagulation Factor II Deficient Plasma Coagulation Factor II Deficient Plasma is a human plasma-based reagent for the detection of hereditary or acquired deficiencies of factor II (prothrombin). It is manufactured by immunoabsorption and contains a residual factor concentration of <1% prothrombin activity and normal levels of fibrinogen and other extrinsic clotting factors. Coagulation Factor II Deficient Plasma was designed to be used in combination with Dade Innovin or Thromborel S reagents. Coagulation Factor V Deficient Plasma Coagulation...

Instrument availability Systems and analyzers Sysmex® systems Coagulation Factor II Deficient Plasma Coagulation Factor V Deficient Plasma Coagulation Factor VII Deficient Plasma Coagulation Factor VIII Deficient Plasma Coagulation Factor IX Deficient Plasma Coagulation Factor X Deficient Plasma Coagulation Factor XI Deficient Plasma Coagulation Factor XII Deficient Plasma Single Factors Reagent name Berichrom Factor XIII Factor VIII C

The INNOVANCE VWF Ac Kit is a sensitive, reliable, and convenient test system for direct determination of VWF activity. It employs an advanced new technology that allows the assay to mimic the way in which VWF binds to glycoprotein Ib (GPIb), the major VWF receptor protein on platelets. Latex particles are coated with an antibody against GPIb, to which recombinant GPIb is added. The addition of patient plasma induces a VWF-dependent agglutination, which is detected turbidimetrically. Because the recombinant receptor protein includes two gain-of-function mutations, the assay does not require ristocetin....

Instrument availability Systems and analyzers Reagent name Sysmex® systems Manual method ProC Global INNOVANCE Antithrombin

Reagent name Reagent description and ready-to-use assay features N Antiserum to Human Antithrombin III Immunoassay (antigen) for the quantitative determination of antithrombin in human plasma. Together with an activity assay, an antigen assay for antithrombin can help differentiating antithrombin type (I or II) deficiency.1 Package size INNOVANCE Heparin Anticoagulant Therapy Management The INNOVANCE Heparin Kit features an in vitro diagnostic automated chromogenic assay for the quantitative determination of the activity of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH)...

Instrument availability Systems and analyzers Atellica COAG 360 N Antiserum to Human Antithrombin III INNOVANCE Heparin INNOVANCE Anti-Xa Reagent name Sysmex® systems Other Direct Oral Anticoagulants (Xα) Berichrom α2-Antiplasmin Berichrom Plasminogen Available upon request N Antiserum to Human Plasminogen INNOVANCE D-Dimer D-Dimer Dade Dimertest Latex Assay Manual method D-Dimer Latex Beads Manual method

Reagent name Reagent description Control Plasma N is citrated normal human pooled plasma. Control Plasma N is used for the assessment of the precision and analytical deviation of various analytes in the normal range. This control provides assigned values for the respective available analytes. Control Plasma P is citrated human plasma. Control Plasma P is a precision and accuracy control intended to monitor the performance of various parameters in the pathological range. The control provides assigned values for the respective available analytes. Dade Ci-Trol® 1, 2, and 3 Controls Dade Ci-Trol...

Instrument availability Systems and analyzers Sysmex® systems Dade Ci-Trol 1, 2, and 3 Controls Dade Ci-Trol Coagulation Control Level 1, 2, and 3 Dade Data-Fi Abnormal Fibrinogen Control Plasma Reagent name Control Plasma N LA Control High ProC Control Plasma Dade Ci-Trol Heparin Control, Low Dade Ci-Trol Heparin Control, High INNOVANCE D-Dimer Controls

INNOVANCE Heparin UF Control 2 is used for quality control of the INNOVANCE Heparin/ INNOVANCE Anti-Xa assays for the quantitative determination of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) in citrated human plasma. Concentration of heparin ~0.7 IU/mL. INNOVANCE Heparin LMW Control 1 INNOVANCE Heparin LMW Control 1 is used for quality control of the INNOVANCE Heparin/ INNOVANCE Anti-Xa assays for the quantitative determination of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) in citrated human plasma. Concentration of heparin ~0.4 IU/mL. INNOVANCE...